Dr. Anmin Huang | Immune Oncology | Best Researcher Award

Dr. Anmin Huang, Peking university, China

Anmin Huang is a Ph.D. and M.D. candidate in Gastroenterology and Hepatology at Peking University. His research focuses on cancer immunotherapy, immune-related biomarkers, and hepatocellular carcinoma. He has authored several high-impact publications in leading journals such as ACS Applied Materials & Interfaces, Frontiers in Molecular Biosciences, and Hepatobiliary Pancreatic Diseases International, covering topics such as immune and ferroptosis-related signatures, tumor immune infiltration, and multifunctional tumor vaccines. Additionally, he has contributed to multiple patents, including innovations in apoptotic biomimetic nanoparticles for tumor immunotherapy and efficient anti-cancer tumor vaccines. His work integrates computational and experimental approaches to advance cancer treatment strategies, reflecting his expertise in translational medicine and biomedical engineering.

Professional Profile:

ORCID

Summary of Suitability for Best Researcher Award – Anmin Huang

Dr. Anmin Huang, a Ph.D./MD candidate at Peking University specializing in Gastroenterology and Hepatology, has demonstrated exceptional research contributions in the fields of cancer immunotherapy, hepatocellular carcinoma, and tumor microenvironment analysis. His groundbreaking publications, innovative patents, and impactful translational research make him a strong candidate for the Best Researcher Award.

🎓 Education & Work Experience

Ph.D./MD Candidate | Peking University, Major: Gastroenterology and Hepatology
Researcher | Specializing in immunotherapy, cancer biology, and hepatocellular carcinoma

🏆 Achievements

Research Publications 📚
- Published multiple high-impact papers in ACS Applied Materials & Interfaces, Frontiers in Molecular Biosciences, Hepatobiliary Pancreatic Diseases International, and Engineering
- Developed immune and ferroptosis-related LncRNA signatures for cancer prognosis
- Contributed to the study of tumor immune infiltration and immunotherapy response
Patents & Innovations 🧪
- Holder of two utility model patents for laboratory equipment
- Co-inventor of apoptotic biomimetic nanoparticles for tumor immunotherapy
- Co-inventor of an anti-cancer tumor vaccine with an innovative preparation method

🎖 Awards & Honors

Recognized for cutting-edge research in oncology and immunotherapy
Contributions to novel cancer treatment strategies and immune regulation

Publication Top Notes:

Engineered Apoptosis-Bioinspired Nanoparticles Initiate Immune Cascade for Cancer Immunotherapy of Malignant Ascites

Dr. Dong Hyun Kim, Seoul National University College of Medicine, South Korea

Dong Hyun Kim, born on April 16, 1993, in South Korea, is a clinical researcher and physician specializing in clinical oncology, hematologic malignancy, and translational medicine. He is currently an external clinical researcher in the Division of Hemato-Oncology at Seoul National University Hospital. Dr. Kim earned his Bachelor of Medicine from Seoul National University College of Medicine in 2019, followed by a Master of Medical Science in Translational Medicine, expected in 2024. He has held positions as an intern and resident doctor in internal medicine at Seoul National University Hospital. Dr. Kim’s research has garnered numerous honors, including the Best Oral Presentation Awards at ICBMT 2022 and ICKSH 2024, as well as the prestigious Presidential Oral Presentation at JSMO 2024.

Summary of Suitability for Best Researcher Award: Dong Hyun Kim

Research Excellence: Dong Hyun Kim has demonstrated exceptional contributions to the fields of Clinical Oncology and
Hematologic Malignancy, focusing on translational medicine. His publication record showcases a robust output of 37
articles, with significant works in high-impact journals such as Cells, British Journal of Haematology, and Scientific Reports.
His research spans critical topics, including tumor microenvironments, therapeutic strategies, and the role of artificial
intelligence in oncology

Education:

🎓 Seoul National University College of Medicine, Seoul, Korea

Bachelor of Medicine (2015 ~ 2019)
Master of Medical Science, Department of Translational Medicine (2022 ~ 2024)

Professional Experience:

🏥 Seoul National University Hospital

Intern (2019 ~ 2020)
Resident Doctor, Department of Internal Medicine (2020 ~ 2023)
External Clinical Researcher, Division of Hemato-Oncology (2023 ~ Present)

Honors & Awards 🏅:

Best Oral Presentation Award, ICBMT 2022
Presidential Oral Presentation, JSMO 2024
Best Oral Presentation Award, ICKSH 2024

Publication top Notes:

Dual T-cell depletion with individually tailored anti-thymocyte globulin and attenuated dose of post-transplant cyclophosphamide in haploidentical peripheral stem cell transplantation

Phase II trial of posaconazole prophylaxis during anti-thymocyte globulin treatment for aplastic anaemia and hypoplastic myelodysplastic syndrome

Effects of tertiary palliative care on the pattern of end-of-life care in patients with hematologic malignancies in Korea

Impact of PIK3CA and cell cycle pathway genetic alterations on durvalumab efficacy in patients with head and neck squamous cell carcinoma: Post hoc analysis of TRIUMPH study